Drug Interactions
Comprehensive guide to drug-drug interactions, pharmacokinetic interactions, and interaction management.
Browse the pages below for detailed information.
lorcaserin — 5-HT2C receptor Interaction
Drug-target interaction between lorcaserin and 5-HT2C receptor. Synthetic organic pharmacological agent targeting this protein.
lorlatinib — ALK receptor tyrosine kinase Interaction
Drug-target interaction between lorlatinib and ALK receptor tyrosine kinase. Synthetic organic pharmacological agent targeting this protein.
lorlatinib — c-ros oncogene 1, receptor tyrosine kinase Interaction
Drug-target interaction between lorlatinib and c-ros oncogene 1, receptor tyrosine kinase. Synthetic organic pharmacological agent targeting this protein.
losartan — AT1 receptor Interaction
Drug-target interaction between losartan and AT1 receptor. Synthetic organic pharmacological agent targeting this protein.
lovastatin — hydroxymethylglutaryl-CoA reductase Interaction
Drug-target interaction between lovastatin and hydroxymethylglutaryl-CoA reductase. Natural product pharmacological agent targeting this protein.
loxapine — 5-HT2A receptor Interaction
Drug-target interaction between loxapine and 5-HT2A receptor. Synthetic organic pharmacological agent targeting this protein.
loxapine — 5-HT2C receptor Interaction
Drug-target interaction between loxapine and 5-HT2C receptor. Synthetic organic pharmacological agent targeting this protein.
loxapine — D2 receptor Interaction
Drug-target interaction between loxapine and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
loxapine — D3 receptor Interaction
Drug-target interaction between loxapine and D3 receptor. Synthetic organic pharmacological agent targeting this protein.
loxapine — D4 receptor Interaction
Drug-target interaction between loxapine and D4 receptor. Synthetic organic pharmacological agent targeting this protein.
lubiprostone — ClC-2 Interaction
Drug-target interaction between lubiprostone and ClC-2. Synthetic organic pharmacological agent targeting this protein.
lumiracoxib — COX-2 Interaction
Drug-target interaction between lumiracoxib and COX-2. Synthetic organic pharmacological agent targeting this protein.
lurasidone — 5-HT7 receptor Interaction
Drug-target interaction between lurasidone and 5-HT7 receptor. Synthetic organic pharmacological agent targeting this protein.
lusutrombopag — Thrombopoietin receptor Interaction
Drug-target interaction between lusutrombopag and Thrombopoietin receptor. Synthetic organic pharmacological agent targeting this protein.
macimorelin — ghrelin receptor Interaction
Drug-target interaction between macimorelin and ghrelin receptor. Synthetic organic pharmacological agent targeting this protein.
macitentan — ETA receptor Interaction
Drug-target interaction between macitentan and ETA receptor. Synthetic organic pharmacological agent targeting this protein.
maprotiline — NET Interaction
Drug-target interaction between maprotiline and NET. Synthetic organic pharmacological agent targeting this protein.
maraviroc — CCR5 Interaction
Drug-target interaction between maraviroc and CCR5. Synthetic organic pharmacological agent targeting this protein.
margetuximab — erb-b2 receptor tyrosine kinase 2 Interaction
Drug-target interaction between margetuximab and erb-b2 receptor tyrosine kinase 2. Antibody pharmacological agent targeting this protein.
mavorixafor — CXCR4 Interaction
Drug-target interaction between mavorixafor and CXCR4. Synthetic organic pharmacological agent targeting this protein.
mazindol — DAT Interaction
Drug-target interaction between mazindol and DAT. Synthetic organic pharmacological agent targeting this protein.
mecamylamine — nicotinic acetylcholine receptor α3 subunit Interaction
Drug-target interaction between mecamylamine and nicotinic acetylcholine receptor α3 subunit. Synthetic organic pharmacological agent targeting this protein.
meclofenamic acid — COX-1 Interaction
Drug-target interaction between meclofenamic acid and COX-1. Synthetic organic pharmacological agent targeting this protein.
meclofenamic acid — COX-2 Interaction
Drug-target interaction between meclofenamic acid and COX-2. Synthetic organic pharmacological agent targeting this protein.
medroxyprogesterone — Progesterone receptor Interaction
Drug-target interaction between medroxyprogesterone and Progesterone receptor. Synthetic organic pharmacological agent targeting this protein.
mefenamic acid — COX-1 Interaction
Drug-target interaction between mefenamic acid and COX-1. Synthetic organic pharmacological agent targeting this protein.
mefenamic acid — COX-2 Interaction
Drug-target interaction between mefenamic acid and COX-2. Synthetic organic pharmacological agent targeting this protein.
melatonin — MT1 receptor Interaction
Drug-target interaction between melatonin and MT1 receptor. Metabolite pharmacological agent targeting this protein.
melatonin — MT2 receptor Interaction
Drug-target interaction between melatonin and MT2 receptor. Metabolite pharmacological agent targeting this protein.
meloxicam — COX-2 Interaction
Drug-target interaction between meloxicam and COX-2. Synthetic organic pharmacological agent targeting this protein.
mepyramine — H1 receptor Interaction
Drug-target interaction between mepyramine and H1 receptor. Synthetic organic pharmacological agent targeting this protein.
mesalazine — Peroxisome proliferator-activated receptor-γ Interaction
Drug-target interaction between mesalazine and Peroxisome proliferator-activated receptor-γ. Synthetic organic pharmacological agent targeting this protein.
methadone — μ receptor Interaction
Drug-target interaction between methadone and μ receptor. Synthetic organic pharmacological agent targeting this protein.
methazolamide — carbonic anhydrase 7 Interaction
Drug-target interaction between methazolamide and carbonic anhydrase 7. Synthetic organic pharmacological agent targeting this protein.
methimazole — thyroid peroxidase Interaction
Drug-target interaction between methimazole and thyroid peroxidase. Synthetic organic pharmacological agent targeting this protein.
methotrexate — dihydrofolate reductase Interaction
Drug-target interaction between methotrexate and dihydrofolate reductase. Synthetic organic pharmacological agent targeting this protein.
methoxamine — α1A-adrenoceptor Interaction
Drug-target interaction between methoxamine and α1A-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
methylnaltrexone — μ receptor Interaction
Drug-target interaction between methylnaltrexone and μ receptor. Synthetic organic pharmacological agent targeting this protein.
methylphenidate — DAT Interaction
Drug-target interaction between methylphenidate and DAT. Synthetic organic pharmacological agent targeting this protein.
methylphenidate — NET Interaction
Drug-target interaction between methylphenidate and NET. Synthetic organic pharmacological agent targeting this protein.
methylprednisolone — Glucocorticoid receptor Interaction
Drug-target interaction between methylprednisolone and Glucocorticoid receptor. Metabolite pharmacological agent targeting this protein.
methyltyrosine — L-Tyrosine hydroxylase Interaction
Drug-target interaction between methyltyrosine and L-Tyrosine hydroxylase. Metabolite pharmacological agent targeting this protein.
methysergide — 5-HT2B receptor Interaction
Drug-target interaction between methysergide and 5-HT2B receptor. Synthetic organic pharmacological agent targeting this protein.
methysergide — 5-HT2C receptor Interaction
Drug-target interaction between methysergide and 5-HT2C receptor. Synthetic organic pharmacological agent targeting this protein.
metoclopramide — 5-HT3A Interaction
Drug-target interaction between metoclopramide and 5-HT3A. Synthetic organic pharmacological agent targeting this protein.
metoclopramide — 5-HT3AB Interaction
Drug-target interaction between metoclopramide and 5-HT3AB. Synthetic organic pharmacological agent targeting this protein.
metoclopramide — 5-HT4 receptor Interaction
Drug-target interaction between metoclopramide and 5-HT4 receptor. Synthetic organic pharmacological agent targeting this protein.
metoclopramide — D2 receptor Interaction
Drug-target interaction between metoclopramide and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
metolazone — Na-Cl symporter Interaction
Drug-target interaction between metolazone and Na-Cl symporter. Synthetic organic pharmacological agent targeting this protein.
metoprolol — β1-adrenoceptor Interaction
Drug-target interaction between metoprolol and β1-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
metyrapone — CYP11B1 Interaction
Drug-target interaction between metyrapone and CYP11B1. Synthetic organic pharmacological agent targeting this protein.
mexiletine — Nav1.4 Interaction
Drug-target interaction between mexiletine and Nav1.4. Synthetic organic pharmacological agent targeting this protein.
mianserin — 5-HT2A receptor Interaction
Drug-target interaction between mianserin and 5-HT2A receptor. Synthetic organic pharmacological agent targeting this protein.
mianserin — 5-HT2B receptor Interaction
Drug-target interaction between mianserin and 5-HT2B receptor. Synthetic organic pharmacological agent targeting this protein.
mianserin — 5-HT2C receptor Interaction
Drug-target interaction between mianserin and 5-HT2C receptor. Synthetic organic pharmacological agent targeting this protein.
midostaurin — fms related receptor tyrosine kinase 3 Interaction
Drug-target interaction between midostaurin and fms related receptor tyrosine kinase 3. Synthetic organic pharmacological agent targeting this protein.
mifepristone — Glucocorticoid receptor Interaction
Drug-target interaction between mifepristone and Glucocorticoid receptor. Synthetic organic pharmacological agent targeting this protein.
mifepristone — Progesterone receptor Interaction
Drug-target interaction between mifepristone and Progesterone receptor. Synthetic organic pharmacological agent targeting this protein.
miglitol — alpha glucosidase Interaction
Drug-target interaction between miglitol and alpha glucosidase. Synthetic organic pharmacological agent targeting this protein.
miglitol — maltase-glucoamylase Interaction
Drug-target interaction between miglitol and maltase-glucoamylase. Synthetic organic pharmacological agent targeting this protein.